Sept 11 (Reuters) – The U.S. Food and Drug Administration on Friday approved Scholar Rock’s therapy to treat a rare genetic condition that causes muscle weakness.
(Reporting by Sneha S K in Bengaluru; Editing by Tasim Zahid)
US FDA approves Scholar Rock’s muscle weakness drug
Sep 11, 2026 | 4:27 PM
Fri Sep 11
Wausau, WI, USA
77°FFeels Like: 78°F
Wind/Dir: 30 MPH-S
Humidity: 57%
On Air Now
Comments